The permission for CT of the Russian drug for the treatment of Parkinson’s disease was obtained
The Ministry of Health of Russia issued a permit to LLC Rionis to conduct clinical studies of the first phase of the drug Prottremin (Diol) for the treatment of Parkinson’s disease. Rionis is allowed to begin an assessment of the safety, tolerability and pharmacokinetic parameters of the drug on healthy volunteers. This study is planned…